In order to promote the scientific supervision of medical devices in China, help enterprises understand post-marketing regulatory policies and governments' measures in post-marketing regulation for medical devices, and strengthen quality control and ensure the development of compliance and self-discipline, China Association for Medical Devices Industry (CAMDI）held "Training Session on Post-marketing Regulatory Policies for Medical Devices" in Beijing on April 17 to 18, 2019.
Leaders from the Department of Medical Device Supervision, Center for Drug Reevaluation and Center for Drug Inspection of NMPA, and National Institute for Food and Drug Control (NIFDC) attended the session and lectured on relevant matters. Zhao Yixin, Chairman of CAMDI, and Yang Xiaofang, Deputy Secretary General of Regulation and Technology Department of CAMDI, attended the session and made speeches.
Head Wang Zhexiong, Director Yue Xianghui, and Director Zhu Ning from the Department of Medical Device Supervision, Wang Gang, a teacher of Center for Drug Reevaluation, Zhu Jiong, Director of NIFDC, Zhang Xintao, Director of NIFDC, Guo Zhun and Wei Lan, teachers of Center for Drug Inspection, attended the session and thoroughly and carefully interpreted relevant issues.
During the training, representatives listened carefully to the lectures and asked questions actively, and the specialists patiently explained such questions with the harmonious atmosphere. Lastly, Yang Xiaofang, Deputy Secretary General of CAMDI, summarized the session and gave thanks to the support of leaders, experts and representatives. CAMDI will continue to collect the needs and advise of its member units and carry out targeted high-quality training in an attempt to help enterprises solve practical problems and promote the compliance development of the medical industry.